A New Chapter in Alzheimer’s Treatment
Our Co-Director, Julie Adams, recently had the opportunity to speak with Ron Wilson on 2SM about a major development in the fight against Alzheimer’s disease: the Australian approval of donanemab, a new treatment that offers real hope for patients and families. Donanemab is a monoclonal antibody that targets amyloid plaques in the brain, aiming to […]
